Catalyst Receivables Turnover from 2010 to 2024
| CPRX Stock | USD 15.62 0.14 0.89% |
Receivables Turnover | First Reported 2010-12-31 | Previous Quarter 7.44111821 | Current Value 11 | Quarterly Volatility 5.03134345 |
Check Catalyst Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Catalyst Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Expense of 5 M, Other Operating Expenses of 327 M or Operating Income of 91.2 M, as well as many indicators such as Price To Sales Ratio of 4.26, Dividend Yield of 0.0 or PTB Ratio of 4.38. Catalyst financial statements analysis is a perfect complement when working with Catalyst Pharmaceuticals Valuation or Volatility modules.
Catalyst | Receivables Turnover |
Latest Catalyst Pharmaceuticals' Receivables Turnover Growth Pattern
Below is the plot of the Receivables Turnover of Catalyst Pharmaceuticals over the last few years. It is Catalyst Pharmaceuticals' Receivables Turnover historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Catalyst Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Receivables Turnover | 10 Years Trend |
|
Receivables Turnover |
| Timeline |
Catalyst Receivables Turnover Regression Statistics
| Arithmetic Mean | 11.41 | |
| Geometric Mean | 10.47 | |
| Coefficient Of Variation | 44.09 | |
| Mean Deviation | 3.66 | |
| Median | 9.71 | |
| Standard Deviation | 5.03 | |
| Sample Variance | 25.31 | |
| Range | 17.6288 | |
| R-Value | 0.54 | |
| Mean Square Error | 19.44 | |
| R-Squared | 0.29 | |
| Significance | 0.04 | |
| Slope | 0.60 | |
| Total Sum of Squares | 354.40 |
Catalyst Receivables Turnover History
About Catalyst Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Catalyst Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Catalyst Pharmaceuticals investors use historical funamental indicators, such as Catalyst Pharmaceuticals's Receivables Turnover, to determine how well the company is positioned to perform in the future. Although Catalyst Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Catalyst Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Catalyst Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Catalyst Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Catalyst Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Receivables Turnover | 7.44 | 11.00 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| SGC | Superior Uniform Group | |
| VLN | Valens | |
| GNFT | Genfit |
Additional Tools for Catalyst Stock Analysis
When running Catalyst Pharmaceuticals' price analysis, check to measure Catalyst Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Catalyst Pharmaceuticals is operating at the current time. Most of Catalyst Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Catalyst Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Catalyst Pharmaceuticals' price. Additionally, you may evaluate how the addition of Catalyst Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.